Arcutis Biotherapeutics, Inc.
NASDAQ:ARQT
10.14 (USD) • At close September 19, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|
| Assets: | |||||||
| Current Assets: | |||||||
| Cash & Cash Equivalents
| 89.323 | 53.641 | 96.449 | 65.082 | 63.336 | 39.394 | 3.418 |
| Short Term Investments
| 183.463 | 355.948 | 290.61 | 219.359 | 37.929 | 11.546 | 0 |
| Cash and Short Term Investments
| 272.786 | 409.589 | 387.059 | 284.441 | 101.265 | 50.94 | 3.418 |
| Net Receivables
| 25.807 | 8.458 | 0.362 | 0.51 | 0 | 0 | 0 |
| Inventory
| 13.134 | 7.514 | 1.18 | -0.51 | 0 | 0 | 0 |
| Other Current Assets
| 18.704 | 10.611 | 14.172 | 8.385 | 5.209 | 0.158 | 0.401 |
| Total Current Assets
| 330.431 | 437.406 | 402.773 | 292.826 | 106.474 | 51.098 | 3.819 |
| Non-Current Assets: | |||||||
| Property, Plant & Equipment, Net
| 3.9 | 4.602 | 5.301 | 5.365 | 0.491 | 0 | 0 |
| Goodwill
| 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets
| 6.438 | 7.188 | 0 | 0 | 0 | 0 | 0 |
| Goodwill and Intangible Assets
| 6.438 | 7.188 | 0 | 0 | 0 | 0 | 0 |
| Long Term Investments
| 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Tax Assets
| 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets
| 0.596 | 0.078 | 0.078 | 0.078 | 0.047 | 0 | 0 |
| Total Non-Current Assets
| 10.934 | 11.868 | 5.379 | 5.443 | 0.538 | 0 | 0 |
| Total Assets
| 341.365 | 449.274 | 408.152 | 298.269 | 107.012 | 51.098 | 3.819 |
| Liabilities & Equity: | |||||||
| Current Liabilities: | |||||||
| Account Payables
| 11.992 | 8.827 | 7.353 | 7.14 | 1.405 | 1.801 | 0.537 |
| Short Term Debt
| 0.735 | 0.657 | 0.433 | 0 | 0.178 | 0 | 0 |
| Tax Payables
| 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue
| 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities
| 33.941 | 28.323 | 25.54 | 15.462 | 3.654 | 0.872 | 0.155 |
| Total Current Liabilities
| 46.668 | 37.807 | 33.326 | 22.602 | 5.237 | 2.673 | 0.692 |
| Non-Current Liabilities: | |||||||
| Long Term Debt
| 201.799 | 201.886 | 77.124 | 4.964 | 0.129 | 0 | 0.966 |
| Deferred Revenue Non-Current
| 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Tax Liabilities Non-Current
| 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities
| 4.231 | 0 | 0.025 | 0.082 | 166.675 | 72.412 | 7.154 |
| Total Non-Current Liabilities
| 206.03 | 201.886 | 77.149 | 5.046 | 166.804 | 72.412 | 8.12 |
| Total Liabilities
| 252.698 | 239.693 | 110.475 | 27.648 | 172.041 | 75.085 | 8.812 |
| Equity: | |||||||
| Preferred Stock
| 0 | 0 | 0 | 298.269 | 166.491 | 72.252 | 7.154 |
| Common Stock
| 0.009 | 0.006 | 0.005 | 0.004 | 0 | 0 | 0 |
| Retained Earnings
| -981.904 | -719.764 | -408.306 | -201.95 | -66.272 | -24.276 | -5.021 |
| Accumulated Other Comprehensive Income/Loss
| 0.004 | -1.086 | -0.255 | -0.002 | -0.001 | 0 | 0 |
| Other Total Stockholders Equity
| 1,070.558 | 930.425 | 706.233 | 174.3 | -165.247 | -71.963 | -7.126 |
| Total Shareholders Equity
| 88.667 | 209.581 | 297.677 | 270.621 | -65.029 | -23.987 | -4.993 |
| Total Equity
| 88.667 | 209.581 | 297.677 | 270.621 | -65.029 | -23.987 | -4.993 |
| Total Liabilities & Shareholders Equity
| 341.365 | 449.274 | 408.152 | 298.269 | 107.012 | 51.098 | 3.819 |